Martins Junior, Carlos Roberto
Martinez, Alberto Rolim Muro
Vasconcelos, Ingrid Faber
de Rezende, Thiago Junqueira Ribeiro
Casseb, Raphael Fernandes
Pedroso, Jose Luiz
Barsottini, Orlando Graziani Povoas
Lopes-Cendes, Íscia
França Jr, Marcondes Cavalcante
Funding for this research was provided by:
Fundação de Amparo à Pesquisa do Estado de São Paulo (2013/01766-7)
Article History
Received: 26 May 2018
Revised: 29 September 2018
Accepted: 8 October 2018
First Online: 15 October 2018
Compliance with ethical standards
:
: Casseb reports grants from FAPESP. Rezende reports grants from FAPESP; Dr Faber reports grants from CNPq (Brazilian National Council for Scientific and -Technological Development) during the conduct of the study; Dr Martinez reports grants from FAPESP during the conduct of this study; Dr Lopes-Cendes reports grants from FAPESP and CNPq, during the conduct of the study. Dr França Jr reports grants from FAPESP and CNPq. Dr Barsottini reports grants from FAPESP and CNPq, during the conduct of the study. Dr Pedroso reports grants from FAPESP and CNPq, during the conduct of the study. The authors declare that they have no conflict of interest. Marcondes C França Jr: reports grants from FAPESP during the conduct of this study. He also received research support from PTC therapeutics, Cristália and Pfizer; took part in advisory boards for Genzyme, Pfizer, Baxter and CSL-Behring; Received travel Grant from Pfizer, Baxter and PTC therapeutics.